| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |